Correlation between the average ganglion cell + inner plexiform layer thickness and contrast sensitivity vision measured with the Pelli Robson test in patients with multiple sclerosis.

<p>Dark symbols represent data from patients with a previous episode of optic neuritis, whereas light symbols represent patients without a previous episode of optic neuritis.</p

Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson’s disease - Fig 3

<p>Three-dimensional graphical representation of the peripapillary choroidal thickness (PPCT) measurements in controls eyes (teaching population in left fig, validating population in middle fig) and Parkinson´s disease (PD) eyes in right fig. Grey, cubes corresponding with the optic nerve head; yellow, PPCT <105 μm; green, mean PPCT ranging from 105 to 139 μm; blue, mean PPCT ranging from 140 to 174 μm; and orange, mean PPCT ≥175 μm.</p

Correlation between structural parameters and contrast sensitivity vision in patients with multiple sclerosis.

<p>Correlation between structural parameters and contrast sensitivity vision in patients with multiple sclerosis.</p

Correlation between structural measurements and color vision in patients with multiple sclerosis.

<p>Correlation between structural measurements and color vision in patients with multiple sclerosis.</p

Visual function and structural parameters in healthy controls and subjects with multiple sclerosis.

<p>Visual function and structural parameters in healthy controls and subjects with multiple sclerosis.</p

Correlation between structural parameters and visual acuity in patients with MS.

<p>Correlation between structural parameters and visual acuity in patients with MS.</p

Correlation between visual acuity as measured with ETDRS optotipe at a contrast level of 100% and the average ganglion cell + inner plexiform layer thickness in patients with multiple sclerosis.

<p>Dark symbols represent data from patients with a previous episode of optic neuritis, whereas light symbols represent patients without a previous episode of optic neuritis.</p

Macular and peripapillary choroidal thickness and volume measured with swept-source deep range imaging optical coherence tomography in patients with Parkinson’s disease and healthy controls.

<p>Macular and peripapillary choroidal thickness and volume measured with swept-source deep range imaging optical coherence tomography in patients with Parkinson’s disease and healthy controls.</p

Descriptive, clinical data, choroidal thicknesses and volume for eyes of patients with Parkinson’s disease and from healthy controls (validating population).

<p>Descriptive, clinical data, choroidal thicknesses and volume for eyes of patients with Parkinson’s disease and from healthy controls (validating population).</p

Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson’s disease - Fig 4

<p>Representation of the mean peripapillary choroidal thickness (PPCT) for the 26×26 cube-grid centered on the optic disc for the three groups: the 40 right healthy eyes of the teaching population (left fig), the 40 right eyes of the healthy validating population (middle fig), and the 40 right eyes of the Parkinson´s disease (PD) patient group (right fig). Grey, cubes corresponding with the optic nerve head; yellow, mean PPCT <105 μm; green, mean PPCT ranging from 105 to 139 μm; blue, mean PPCT ranging from 140 to 174 μm; and orange, mean PPCT ≥175 μm. The temporosuperior choroid is the thickest, followed by superior, temporal, nasal, and inferior choroid.</p